GlassScriptPhysician profile
Melissa Rae Lim
NPI 1962288464
$2,949.63
in general payments reported to CMS, 2019-2025
14 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $97.64 · 2024: $2,425 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,949.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $811.44 | 2023-2025 | |
| Abbvie INC. | $801.10 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $450.16 | 2023-2025 | Dupixent, Libtayo |
| Ucb, INC. | $217.08 | 2024-2025 | Bimzelx |
| Incyte Corporation | $138.81 | 2024 | Opzelura |
| Lilly USA, LLC | $102.03 | 2024-2025 | Olumiant, Ebglyss, Taltz |
| Dermavant Sciences, INC. | $91.34 | 2024 | Vtama |
| Amgen INC. | $77.02 | 2024-2025 | Otezla, Otezla |
| Leo Pharma INC. | $72.32 | 2024-2025 | Adbry |
| Pfizer INC. | $59.20 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $45.85 | 2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $33.62 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $25.09 | 2025 | |
| Biofrontera INC. | $24.57 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.